Experimentally induced panic attacks;Die experimentelle provokation von panikattacken als humanexperimentelles angstmodell

Nervenarzt

Volumn 74, Issue 9, 2003, Pages 733-739

  Strohle A ^a,b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Anxiety; Experimental anxiety; Neurobiology of anxiety; Panic; Panic disorder

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; ADRENERGIC RECEPTOR STIMULATING AGENT; ATRIAL NATRIURETIC FACTOR; BICARBONATE; CAFFEINE; CHOLECYSTOKININ; CLONIDINE; LACTIC ACID DERIVATIVE; LAURIC ACID; LAURIC ACID DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; TETRAPEPTIDE;

ANXIETY; ANXIETY DISORDER; BEHAVIOR; COGNITION; COMPARATIVE STUDY; DIAGNOSTIC TEST; DISEASE MODEL; EMOTION; HUMAN; IATROGENIC DISEASE; INFUSION; LOCUS CERULEUS; NEUROBIOLOGY; NEUROTRANSMISSION; NORADRENERGIC SYSTEM; PANIC; PATHOPHYSIOLOGY; PROVOCATION; PSYCHIATRIC DIAGNOSIS; REVIEW; SEROTONINERGIC TRANSMISSION; SYMPTOMATOLOGY; TRANQUILIZING ACTIVITY;

ANXIETY DISORDERS; ATRIAL NATRIURETIC FACTOR; BICARBONATES; CAFFEINE; DISEASE MODELS, ANIMAL; LACTATES; LAURIC ACIDS; PANIC DISORDER; SYMPATHOMIMETICS;

EID: 0141839701     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-002-1385-1     Document Type: Review

References (46)

1. Bidzseranova A, Toth G, Telegdy G (1991) The effects of atrial natriuretic peptide on the open-field activity of rats. The role of neurotransmitters. Neuropeptides 20:163-167
2. Bonn JA, Harrison J, Rees L (1973) Lactate infusion in the treatment of 'flee-floating' anxiety. Canad Psychiat Ass J 18:41-46
3. Bradwejn J, Koszycki D (1991) Comparison of the panicogenic effects of cholecystokinin 30-33 and carbon dioxide in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 15:237-239
4. Bradwejn J, Koszycki D, Shriqui C (1991) Enhanced sensitivity to cholecystokinin tetrapetide in panic disorder. Arch Gen Psychiatry 48:603-610
5. Bradwejn J, Koszycki D (1994) Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients. Am J Psychiatry 151:261-263
6. Cameron OG, Lee MA, Curtis GC, McCann DS (1987) Endocrine and physiological changes during "spontaneous" panic attacks. Psychoneuroendocrinology 12:321-331
7. Charney DS, Heninger GR (1986) Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 43:1042-1054
8. Charney DS, Heninger GR, Breier A (1984) Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 41:751-763
9. De Bold AJ, Borenstein HB, Veress AT, Sonnenberg H (1981) A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci 28:89-94
10. De Montigny C (1989) Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers: preliminary findings. Arch Gen Psychiatry 46:511-517
11. Dorow R, Horowski R, Paschelke G, Amin M, Braestrup C (1982) Severe anxiety induced by FG 7142 a beta-carboline ligand for benzodiazepine receptors. Lancet 2:98-99.
12. Gorman JM, Fyer MR, Goetz R et al. (1988) Ventilatory physiology of patients with panic disorder. Arch Gen Psychiatry 45:31-39
13. Hunkeler W, Mohler H, Pieri L, Polc P, Bonetti EP, Cumin R (1981) Selective antagonists of benzodiazepines. Nature 290:514-516
14. Imura H, Nakao K, Itoh H (1992) The natriuretic peptide system in the brain: Implications in the central control of cardiovascular and neuroendocrine functions. Front Neuroendocrinol 3:217-249
15. Kahn RS,Asnis GM, Wetzler S, van Praag HM (1988) Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder. Psychopharmacology (Berl) 96:360-364
16. Kellner M, Herzog L, Yassouridis A, Holsboer F, Wiedemann K (1995) A possible role of atrial natriuretic hormone in pituitary-adrenocortical unresponsiveness in lactate-induced panic. Am J Psychiatry 152:1365-1367
17. Kellner M, Wiedemann K, Holsboer F (1992) ANF inhibits the CRH-stimulated secretion of ACTH and cortisol in man. Life Sci 1992;50:1835-1842
18. Kramer MS, Cutler NR, Ballenger JC et al. (1995) A placebo-controlled trial of L-365,260, a CCK-B antagonist, in panic disorder. Biol Psychiatry 37:462-466
19. Lesch KP, Wiesmann M, Hoh A, Muller T, Disselkamp-Tietze J, Osterheider M, Schulte HM (1992) 5-HT1A receptor-effector system responsivity in panic disorder. Psychopharmacology (Berl) 106:111-117
20. Liebowitz MR, Fyer AJ, McGranth P (1981) Clonidine treatment of panic disorder. Psychopharmacol Bull 17:122-123
21. Nutt DJ, Glue P, Lawson C, Wilson S (1990) Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder. Arch Gen Psychiatry 47:917-925
22. Pande CA (1997) Lack of efficacy of a cholecystokinin-B antagonist in anxiety disorders. Biol Psychiatry 42:11-19
23. 2 in patients with panic disorder. Am J Psychiatry 153:1060-1064
24. Pitts FM, McClure JN (1967) Lactate metabolism in anxiety neurosis. New England J Med 177:1329-1336
25. Poggioli R, Vergoni AV, Rasori E, Marrama D, Bertolini A (1992) Behavioral effects of atriopeptin in rats. Neuropeptides 22:149-154
26. Randall PK, Bremner JD, Krystal JH, Nagy LM, Heninger GR, Nicolaou AL, Charney DS (1995) Effects of the benzodiazepine antagonist flumazenil in PTSD. Biol Psychiatry 138:319-324
27. Reed V, Wittchen HU (1998) DSM-IV panic attacks and panic disorder in a community sample of adolescents and young adults: how specific are panic attacks? J Psychiatric Res 32:335-345
28. Roy-Byrne PP, Cowley DS, Greenblatt DJ, Shader RI, Hommer D (1990) Reduced benzodiazepine sensitivity in panic disorder. Arch Gen Psychiatry. 47:534-538
29. Schöpf J, Laurian S, Gaillard JM (1984) Intrinsic activity of the benzodiazepine antagonist Ro 15-1788 in man. An electrophysiological investigation. Pharmacopsychiatry 17:79-83
30. Seibyl JP, Krystal JH, Price LH,Woods SW, D'Amico C, Heninger GR, Charney DS (1991) Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects. Psychiatry Res 38:227-236
31. Shear MK, Fyer AJ, Ball G et al. (1991) Vulnerability to sodium lactate in panic disorder patients given cognitive behavioral therapy. Am J Psychiatry 148:795-797
32. Shlik J, Aluoja A, Vasar V, Vasar E, Podar T, Bradwejn J (1997) Effects of citalopram treatment on behavioral cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder. J Psychiatry Neurosci 22:332-340
33. Steiger A, Guldner J, Lauer CJ, Meschenmoser C, Pollmächer T, Holsboer F (1994) Flumazenil exerts intrinsic activity on sleep EEG and nocturnal hormone secretion. Psychopharmacology 113:334-338
34. Ströhle A, Jahn H, Montkowski A et al. (1997) Central and peripheral administration of atriopeptin is anxiolytic in rats. Neuroendocrinology 65:210-215
35. Ströhle A, Kellner M, Yassouridis A, Holsboer F, Wiedemann K (1998) Effect of flumazenil in lactate-sensitive patients with panic disorder. Am J Psychiatry 155:610-612
36. Ströhle A, Kellner M, Holsboer F, Wiedemann K (1998) Atrial natriuretic hormone decreases endocrine response to a combined dexamethasone corticotropin-releasing hormone test. Biol Psychiatry 43:371-375
37. Ströhle A, Kellner M, Holsboer F, Wiedemann K (1999) Behavioral, neuroendocrine and cardiovascular response to flumazenil. No evidence for an altered benzodiazepine receptor sensitivity in panic disorder. Biol Psychiatry 45:321-326
38. Ströhle A, Holsboer F, Rupprecht R (2000) Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder. Neuropsychopharmacology 22:251-256
39. Ströhle A, Kellner M, Holsboer F, Wiedemann K (2001) Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder. Am J Psychiatry 158:1514-1516
40. A receptor modulatory neuroactive steroid composition in patients with panic disorder. Preliminary results. Arch Gen Psychiatry (im Druck)
41. Sudoh T, Kangawa K, Minamino N, Matsuo H (1988) A new natriuretic peptide in porcine brain. Nature 1988;332:78-81
42. Svenson TH, Usdin T (1978) Feedback inhibition of brain noradrenaline neurons by tricyclic antidepressants: alpha-receptor mediation. Science 202:1089-1091
43. Targum SD, Marshall LE (1989) Fenfluramine provocation of anxiety in patients with panic disorder. Psychiatry Res 28:295-306
44. Wiedemann K, Jahn H, Yassouddis A, Kellner M (2001) Anxiolytic activity of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks. Arch Gen Psychiatry 58:371-377
45. Woods SW, Charney DS, McPherson CA, Gradman AH, Heninger GR (1987) Situational panic attacks. Behavioral physiologic and biochemical characterization. Arch Gen Psychiatry 44:365-375
46. Zwansger P, Baghai TC, Schuele C et al (2001) Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers. Neuropsychopharmacology 25:699-703